Evidence map›Paper›PMID 40987458›Full record

ArticleJournal of the American Association for Laboratory Animal Science : JAALAS2025

Mouse Papillomavirus Outbreak in a Research Facility.

Kristin E Killoran, Matthew W Breed, Melody E Roelke-Parker, Susan Carney, Elijah Edmondson, Cynthia D Thompson, John T Schiller, Kenneth Henderson, Cheryl L Woods, Theresa M Albers and 2 more

Abstract read
In one paragraph

Article in Journal of the American Association for Laboratory Animal Science : JAALAS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kristin E Killoran1Laboratory Animal Medicine, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Bethesda, Maryland.
Matthew W Breed1Laboratory Animal Medicine, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Bethesda, Maryland.
Melody E Roelke-Parker1Laboratory Animal Medicine, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Bethesda, Maryland.
Susan Carney2Animal Diagnostic Laboratory and Genotyping Core, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
Elijah Edmondson3Molecular Histopathology Laboratory, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
Cynthia D Thompson4Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
John T Schiller4Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Kenneth Henderson5Charles River Laboratories, Wilmington, Massachusetts; and.
Cheryl L Woods5Charles River Laboratories, Wilmington, Massachusetts; and.
Theresa M Albers5Charles River Laboratories, Wilmington, Massachusetts; and.
Matthew F Starost6Division of Veterinary Resources, Office of the Director, National Institutes of Health, Bethesda, Maryland.
Joshua A Kramer1Laboratory Animal Medicine, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Bethesda, Maryland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of mouse papillomavirus (MmuPV1) to study infections, disease outcomes, and vaccine strategies in mice has greatly enhanced our understanding of human papillomavirus. However, as with other species-specific infectious agents used as models for human disease, such studies may pose a risk to facilities that house large numbers of the model agent's natural host, especially when the full natural history of the infection is uncertain. In this study, we describe our recent experience showing that containment of MmuPV1 can be difficult, and that its use in research facilities may cause unexpected, long-lasting environmental contamination. Following the identification of symptomatic index cases of MmuPV1 in nude mice, we identified widespread contamination of an ∼10,000 cage facility, including MmuPV1 infection in mice of varying strains and immunocompetencies. Concerningly, many years separated the experimental use of MmuPV1 in the facility and our subsequent identification of index cases. We report our methods to identify, survey, and eliminate MmuPV1 from the facility, and the evolution of decontamination procedures that proved successful.

Indexed as

CRL, Charles River’s diagnostic laboratoryHPV, human papillomavirusINTC, internal controlMmuPV1, mouse papillomavirusPmel, B6.Cg-Thy1a/Cy Tg(TcraTcrb)8Rest/JPPE, personal protective equipmentqPCR, quantitative PCR

Identifiers

PMID40987458
PMCPMC12694133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.